covid-19-disease

Documents about covid-19-disease

• Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients#967746ClinicalTrials.gov
• Sleep Quality in Healthcare Personnel During COVID-19#980054ClinicalTrials.gov
• The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19#991926ClinicalTrials.gov
• Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID)#891750ClinicalTrials.gov
• Clinical Correlates of COVID-19 Pandemic in Patients With Functional Movement Disorder (FMD) and Parkinson's Disease (PD)#915740ClinicalTrials.gov
• Positive End Espiratory Pressure Trial in Coronavirus Disease 19 Treated With Continuous Positive Airway Pressure#992036ClinicalTrials.gov
• COVID-19 and Science Communication: The Recording and Reporting of Disease Mortality#102913PhilArchive
• The Infectious Disease Ontology in the Age of COVID-19#697378PhilArchive
• Oral Manifestations of Coronavirus Disease 2019(COVID-19) :a Multicentre Study#994798ClinicalTrials.gov
• A Phase 1 Study to Assess the Safety and Immunogenicity of JCXH-221, an MRNA-based Broadly Protective COVID-19 Vaccine#876651ClinicalTrials.gov
• Impact of COVID-19 on GU Disease#864396ClinicalTrials.gov
• Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19#331844UNC Dataverse Dataverse OAI Archive
• Opciones terapéuticas y COVID-19: orientaciones evolutivas, 10 de noviembre de 2023#356067WHO IRIS
• WHO guidelines on the use of chest imaging in COVID-19#404869WHO IRIS
• Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina#829719ClinicalTrials.gov
• The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)#855798ClinicalTrials.gov
• Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction#860848ClinicalTrials.gov
• Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.#869072ClinicalTrials.gov
• Dynamics of Markers of Infection and Inflammation in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients#888478ClinicalTrials.gov
• Association between strategies to prevent COVID-19 infection in long-term care facilities and mortality: the PIANO-COVID-19 study, a French multicentre cohort study#161209HAL (France)
• College students’ well-being during the COVID-19 pandemic : an exploratory study#197792University of Pretoria Repository
• Annexes to the recommendations for use of the Biological E Limited’s Corbevax (BECOV-2) vaccine against COVID-19: grading of evidence, evidence to recommendations tables, first issued 25 September 2023#432273WHO IRIS
• A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.#865972ClinicalTrials.gov
• Antibody Response to COVID-19 Vaccines in Liver Disease Patients#891098ClinicalTrials.gov
• Ensuring a post-COVID economic agenda tackles global biodiversity loss#435162University of Pretoria Repository
• Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure#892709ClinicalTrials.gov
• A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function#966409ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19)#1045991ClinicalTrials.gov
• WHO Declares COVID-19 a Pandemic.#6166OpenAlex
• Children with psoriasis and COVID‐19: factors associated with an unfavourable COVID‐19 course, and the impact of infection on disease progression (Chi‐PsoCov registry)#147461HAL (France)
• Natural Polyphenol Engineering Field Crops based Diet to Promote Innate Immunity to Combat Covid-19 Disease#487013AgriXiv
• Repurposing facilities for quarantine or isolation and management of mild COVID-19 cases#649878WHO IRIS
• Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)#841506ClinicalTrials.gov
• Lifestyle Changes by the COVID-19 (Coronavirus Disease 2019) Pandemic in Children With Developmental Delays#845751ClinicalTrials.gov
• N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)#804454ClinicalTrials.gov
• Safety, Immunogenicity, and Efficacy of INO-4800 for COVID-19 in Adults at High Risk of SARS-CoV-2 Exposure#892368ClinicalTrials.gov
• The concept of disease in the time of COVID-19#706471PhilArchive
• An Observational Study of Patients With Coronavirus Disease 2019#829937ClinicalTrials.gov
• Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)#832105ClinicalTrials.gov
• Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)#870084ClinicalTrials.gov
• Coronavirus Disease 2019 (COVID-19) During Pregnancy: Prevalence of Seroconversion, Effect on Maternal and Perinatal Outcomes and Risk of Vertical Transmission (COVID-MAP)#876892ClinicalTrials.gov
• Parkinson's Disease and Experiences Throughout the COVID-19 Pandemic#867838ClinicalTrials.gov
• COVID-19 infection prevention and control living guideline: mask use in community settings, 22 December 2021#413792WHO IRIS
• A critical review of emerging technologies for tackling COVID ‐19 pandemic#477124OpenAlex
• Understanding the Demographics, Behaviors, Attitudes and the Perceived Barriers that Impede Covid-19 Public Health Mitigation Measures among Residents Of Metro Atlanta#492252ScholarWorks@GSU
• Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients#833934ClinicalTrials.gov
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)#855179ClinicalTrials.gov
• Collaborative Network for Generating Scientific Evidence in COVID-19 For the Unified Health System in Brazil - RECOVER SUS-BRASIL#858140ClinicalTrials.gov
• Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population#874393ClinicalTrials.gov
• Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease#878381ClinicalTrials.gov